Jessica R Kirshner Selected Research

Jessica R Kirshner Research Topics

16	Neoplasms (Cancer) 10/2022 - 08/2008
3	Ovarian Neoplasms (Ovarian Cancer) 12/2020 - 10/2015
2	Prostatic Neoplasms (Prostate Cancer) 01/2020 - 01/2018
2	Breast Neoplasms (Breast Cancer) 01/2017 - 01/2017
1	Cytokine Release Syndrome 01/2021
1	Multiple Myeloma 01/2021
1	Melanoma (Melanoma, Malignant) 08/2008
1	Virus Diseases (Viral Diseases) 07/2005
1	Infections 07/2005

6	AntibodiesIBA 01/2021 - 10/2015
5	Bispecific AntibodiesIBA 01/2021 - 01/2019
5	AntigensIBA 01/2021 - 01/2017
3	Prolactin Receptors (Prolactin Receptor)IBA 01/2018 - 01/2017
2	theasinensin AIBA 01/2021 - 01/2020
2	Programmed Cell Death 1 ReceptorIBA 01/2021 - 01/2021
2	Neoplasm Antigens (Tumor Antigens)IBA 01/2019 - 01/2018
2	Vascular Endothelial Growth Factor A (Vascular Endothelial Growth Factor)IBA 10/2015 - 09/2011
2	LigandsIBA 10/2015 - 09/2011
1	CytokinesIBA 01/2022
1	Blocking AntibodiesIBA 01/2021
1	cemiplimabIBA 01/2021
1	bis(3- bis(4- chlorophenyl)methyl- 4- dimethylaminophenyl)amineIBA 01/2021
1	Chimeric Antigen ReceptorsIBA 01/2021
1	Therapeutic UsesIBA 01/2021
1	B7-H1 AntigenIBA 01/2021
1	CA-125 Antigen (CA 125 Antigen)IBA 01/2019
1	Glycoproteins (Glycoprotein)IBA 01/2019
1	epidermal growth factor receptor VIIIIBA 01/2018
1	Maytansine (Maitansine)IBA 01/2018
1	2-methylcyclopentadienyl manganese tricarbonyl (MMT)IBA 01/2018
1	IsotopesIBA 01/2018
1	Cytokine Receptors (Cytokine Receptor)IBA 01/2017
1	Immunoconjugates (Immunoconjugate)IBA 01/2017
1	Ado-Trastuzumab EmtansineIBA 01/2017
1	Proteins (Proteins, Gene)FDA Link 07/2016
1	Peptides (Polypeptides)IBA 07/2016
1	enoticumabIBA 10/2015
1	Paclitaxel (Taxol)FDA LinkGeneric 08/2008
1	Reactive Oxygen Species (Oxygen Radicals)IBA 08/2008
1	elesclomolIBA 08/2008
1	Messenger RNA (mRNA)IBA 07/2005
1	Interferon Regulatory Factor-3 (Interferon Regulatory Factor 3)IBA 07/2005
1	InterferonsIBA 07/2005
1	TNF-Related Apoptosis-Inducing Ligand ReceptorsIBA 07/2005

5	Therapeutics 01/2021 - 09/2011
2	Immunotherapy 10/2022 - 01/2019
1	Aftercare (After-Treatment) 01/2020
1	Combination Drug Therapy (Combination Chemotherapy) 01/2019